PAVmed (PAVM) Return on Capital Employed Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | -74,146.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -74,146.00 |
| Jun 30, 2025 | -47,275.00 |
| Mar 31, 2025 | -43,486.00 |
| Dec 31, 2024 | 23,482.00 |
| Jun 30, 2024 | 137,143.00 |
| Mar 31, 2024 | 132,567.00 |
| Dec 31, 2023 | 82,786.00 |
| Sep 30, 2023 | 139,988.00 |
| Jun 30, 2023 | -80,365.00 |
| Mar 31, 2023 | -91,406.00 |
| Dec 31, 2022 | -31,888.00 |
| Dec 31, 2019 | -28,549.00 |
| Dec 31, 2018 | -694,731.00 |
| Sep 30, 2018 | -33,855.00 |
| Dec 31, 2017 | 983,625.00 |